Cargando…

Prospective Observational Study of Imatinib Therapy in Japanese Patients with Advanced Gastrointestinal Stromal Tumors: Long-term Follow-up and Second Malignancy

OBJECTIVE: Limited data are available concerning long-term results of imatinib therapy in patients with advanced gastrointestinal stromal tumors. We aimed to clarify the long-term outcomes of imatinib therapy in Japanese patients with advanced gastrointestinal stromal tumors. METHODS: A prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanda, Tatsuo, Ishikawa, Takashi, Hirota, Seiichi, Yajima, Kazuhito, Kosugi, Shin-ichi, Ohashi, Manabu, Suzuki, Satoshi, Mashima, Yasuoki, Ajioka, Yoichi, Hatakeyama, Katsuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299430/ https://www.ncbi.nlm.nih.gov/pubmed/22523393 http://dx.doi.org/10.1093/jjco/hys056

Ejemplares similares

Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation
por: Wakai, T, et al.
Publicado: (2004)

Reexpansion Pulmonary Edema following Laparoscopy-Assisted Distal Gastrectomy for a Patient with Early Gastric Cancer: A Case Report
por: Yajima, Kazuhito, et al.
Publicado: (2012)

Late recurrence of low-risk gastrointestinal stromal tumor of jejunum diagnosed 30 years after tumor resection: A case report and literature review
por: Kanda, Tatsuo, et al.
Publicado: (2022)

Imatinib therapy for a patient with metastasis of colonic gastrointestinal stromal tumor: report of a case
por: Okamura, Takuma, et al.
Publicado: (2013)

Impact of the KIT/PDGFRA genotype on prognosis in imatinib‐naïve Japanese patients with gastrointestinal stromal tumor
por: Cho, Haruhiko, et al.
Publicado: (2021)

Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib
por: Sawaki, Akira, et al.
Publicado: (2014)

WallFlex™ Duodenal Stent Placement in a Gastric Cancer Patient with Malignant Stenosis of a Roux-en-Y Gastrojejunostomy following Distal Gastrectomy
por: Kakuta, Tomoyuki, et al.
Publicado: (2012)

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
por: Sawaki, Akira, et al.
Publicado: (2009)

Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes
por: Shirai, Yoshio, et al.
Publicado: (2012)

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
por: Kurokawa, Yukinori, et al.
Publicado: (2017)

Genomic and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumors
por: Takahashi, Tsuyoshi, et al.
Publicado: (2017)

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
por: Saito, Yurina, et al.
Publicado: (2019)

Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I
por: Nishida, Toshirou, et al.
Publicado: (2015)

Heterogeneity of p53 Mutational Status in Esophageal Squamous Cell Carcinoma
por: Kuwabara, Shirou, et al.
Publicado: (1998)

Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis
por: Ichikawa, Hiroshi, et al.
Publicado: (2015)

Alteration of p53-binding protein 1 expression as a risk factor for local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma
por: Wakai, Toshifumi, et al.
Publicado: (2021)

A giant subcutaneous leiomyosarcoma arising in the inguinal region
por: Yajima, Kazuhito, et al.
Publicado: (2005)

p53 Gene Deficiency Does Not Enhance Instability of Mouse Minisatellites in Somatic Cells of Normal Tissues
por: Ohashi, Manabu, et al.
Publicado: (1996)

Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world
por: Nishida, Toshirou, et al.
Publicado: (2019)

Two-Step Laparoscopic Surgery for a Patient with Synchronous Double Cancer of the Colon and Stomach Accompanied by Severe Chronic Obstructive Pulmonary Disease
por: Yajima, Kazuhito, et al.
Publicado: (2013)

Surgical resection of recurrent gastrointestinal stromal tumor after interruption of long-term nilotinib therapy
por: Sugase, Takahito, et al.
Publicado: (2016)

Imatinib treatment for gastrointestinal stromal tumour (GIST)
por: Lopes, Lisandro F, et al.
Publicado: (2010)

A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours
por: Contreras-Hernández, I, et al.
Publicado: (2008)

Clinical outcomes of second‐generation tyrosine kinase inhibitors versus imatinib in older patients with CML
por: Ono, Takaaki, et al.
Publicado: (2022)

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib
por: Vincenzi, Bruno, et al.
Publicado: (2018)

Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)
por: Fujisawa, Shin, et al.
Publicado: (2018)

Comparison of Dasatinib- and Imatinib-Related Cardiotoxic Adverse Events in Japanese Patients With Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumor
por: Motokawa, Tetsufumi, et al.
Publicado: (2021)

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
por: Din, Omar S, et al.
Publicado: (2008)

Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumor
por: Tetzlaff, Eric D., et al.
Publicado: (2013)

Update on imatinib for gastrointestinal stromal tumors: duration of treatment
por: Linch, Mark, et al.
Publicado: (2013)

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor
por: Serrano, César, et al.
Publicado: (2019)

Clinical outcomes of surgical and imatinib treatment for rectal gastrointestinal stromal tumours: retrospective cohort study
por: Tsukamoto, Shunsuke, et al.
Publicado: (2022)

Multiple Gastric Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1
por: Tomatsu, Makoto, et al.
Publicado: (2016)

Gastric volvulus associated with shrinkage of a gastrointestinal stromal tumor by neoadjuvant imatinib: a case report
por: Sugiyama, Yoichi, et al.
Publicado: (2023)

Mutations of p53 in Morphologically Non‐neoplastic Mucosa of Long‐standing Ulcerative Colitis
por: Takaku, Hideya, et al.
Publicado: (2001)

Imatinib Plasma Monitoring-Guided Dose Modification for Managing Imatinib-Related Toxicities in Gastrointestinal Stromal Tumor Patients
por: Yoon, Shinkyo, et al.
Publicado: (2013)

Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
por: Katsumata, Ryo, et al.
Publicado: (2023)

Imatinib in gastrointestinal stromal tumour: Northern Cancer Network experience
por: Azribi, F, et al.
Publicado: (2009)

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
por: Quek, Richard, et al.
Publicado: (2010)

ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
por: Rink, Lori, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f6skaa91tgdql42vqs1rser537